TSS
CASI

Two Sigma Securities’s CASI Pharmaceuticals CASI Stock Holding History

Two Sigma Securities’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,599
Closed -$13.7K – 1447
2025
Q2 		$13.7K Buy
+11,599
New +$21.3K ﹤0.01% 1276
2022
Q1 		– Sell
-8,867
Closed -$71K – 2139
2021
Q4 		$71K Buy
+8,867
New +$88.3K ﹤0.01% 1220
2018
Q3 		– Sell
-2,280
Closed -$188K – 2606
2018
Q2 		$188K Buy
+2,280
New +$154K ﹤0.01% 2383

Other funds holding CASI

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Two Sigma Securities's CASI Position: Q3 2025 in Review

Two Sigma Securities sold out of CASI Pharmaceuticals (CASI) in Q3 2025, closing a stake of 11,599 shares — an estimated $13.7K sold.

Two Sigma Securities first reported a position in CASI in Q2 2018 and held it in 3 quarters. The position peaked at $188K in Q2 2018. 22 funds tracked by Wall St. Rank hold CASI as of Q3 2025.

  • Two Sigma Securities reported no remaining CASI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 11,599 CASI Pharmaceuticals shares in Q3 2025, an estimated $13.7K.
  • Two Sigma Securities first reported a position in CASI Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Two Sigma Securities's CASI Pharmaceuticals position peaked at $188K in Q2 2018.
  • 22 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.